Evidence map›Paper›PMID 34020663›Full record

ArticleJournal of nanobiotechnology2021

A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances.

Peng Liu, Yanbin Zhou, Xinyi Shi, Yu Yuan, Ying Peng, Surong Hua, Qiange Luo, Jinsong Ding, Yong Li, Wenhu Zhou

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. HSA-miR-34a-5p regulates the SIRT1/TP53 axis in prostate cancer.American journal of translational research · 2022
    Article
  17. Glucose Metabolism Intervention-Facilitated Nanomedicine Therapy.International journal of nanomedicine · 2022
    Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Peng LiuXiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, Hunan, China.
Yanbin ZhouXiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, Hunan, China.
Xinyi ShiXiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, Hunan, China.
Yu YuanXiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, Hunan, China.
Ying PengXiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, Hunan, China.
Surong HuaDepartment of General Surgery, Peking Union Medical College Hospital, Beijing, 100730, China.
Qiange LuoXiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, Hunan, China.
Jinsong DingXiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, Hunan, China.
Yong LiDepartment of Pediatric Surgery, Hunan Children's Hospital, Changsha, 410004, Hunan, China. liyongpuwaike@163.com.
Wenhu ZhouXiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, Hunan, China. zhouwenhuyaoji@163.com.
Central South University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNHunan Children's Hospital · CN

Funding

Innovation-Driven Project of Central South University No. 20170030010004National Natural Science Foundation of China 21804144National Natural Science Foundation of China 82073799National Natural Science Foundation of China U1903125
6 · The paper itself

Abstract

backgroundPhotodynamic therapy (PDT) is a clinically implemented modality to combat malignant tumor, while its efficacy is largely limited by several resistance factors from tumor microenvironment (TME), such as hypoxia, anti-oxidant systems, and ATP-dependent tumor adaptive resistances. The aim of this work is to construct a multifunctional nanoplatform to remodel multiple resistant TME for enhanced PDT.

resultsHere, a targeting nano-reactor was facilely constructed to reverse the multiple resistances of PDT by incorporating glucose oxidase (GOx) and chlorin e6 (Ce6) into poly (D, L-lactic-co-glycolic acid) (PLGA)/ metal-organic framework (MOF) core-shell nanoassembly, with surface deposition of hyaluronic acid (HA) stabilized MnO

conclusionsThis nano-reactor offers a multifunctional nanoplatform to sensitize TME-limited tumor treatment means via reversing multiple resistances.

Indexed as

AnimalsCell Line, TumorChlorophyllidesDrug Resistance, NeoplasmFemaleGlutathioneHumansHydrogen PeroxideManganese CompoundsMetal-Organic FrameworksMiceMice, Inbred BALB CNanoparticlesOxidesParticle SizePhotochemotherapyChlorophyllidesGlutathioneHydrogen PeroxideManganese CompoundsMetal-Organic FrameworksOxidesphytochlorinPorphyrinsDrug resistanceGSH depletionMetal–organic-frameworksNanomedicineOxygenationStarvation therapyTargetingTumor hypoxia

Identifiers

PMID34020663
PMCPMC8139056
OpenAlexW3135008695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.